Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma

SIMPLE SUMMARY: Not all patients with hepatocellular carcinoma (HCC) benefit from treatment with systemic treatments such as sorafenib. Hepatic arterial infusion chemotherapy (HAIC) is the treatment using an indwelling catheter port system. The regimen of HAIC used in the study is New FP which is co...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwamoto, Hideki, Niizeki, Takashi, Nagamatsu, Hiroaki, Ueshima, Kazuomi, Nomura, Takako, Kuzuya, Teiji, Kasai, Kazuhiro, Kooka, Yohei, Hiraoka, Atsushi, Sugimoto, Rie, Yonezawa, Takehiro, Ishihara, Akio, Deguchi, Akihiro, Arai, Hirotaka, Shimose, Shigeo, Shirono, Tomotake, Nakano, Masahito, Okamura, Shusuke, Noda, Yu, Kamachi, Naoki, Sakai, Miwa, Suzuki, Hiroyuki, Aino, Hajime, Matsukuma, Norito, Matsugaki, Satoru, Ogata, Kei, Yano, Yoichi, Ueno, Takato, Kajiwara, Masahiko, Itano, Satoshi, Fukuizumi, Kunitaka, Kawano, Hiroshi, Noguchi, Kazunori, Tanaka, Masatoshi, Yamaguchi, Taizo, Kuromatsu, Ryoko, Kawaguchi, Atsushi, Koga, Hironori, Torimura, Takuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915251/
https://www.ncbi.nlm.nih.gov/pubmed/33562793
http://dx.doi.org/10.3390/cancers13040646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915251/
https://www.ncbi.nlm.nih.gov/pubmed/33562793
http://dx.doi.org/10.3390/cancers13040646

Ejemplares similares